BioCrossroads

BioCrossroads is a unique public-private partnership based in Indianapolis, Indiana, established in 2002 with the mission to advance the state's life sciences and high-tech sectors. Unlike a traditional venture capital firm, BioCrossroads functions as a strategic catalyst for economic development, encompassing direct investment, talent attraction, and collaborative initiatives. Its overarching goal is to foster innovation and growth within Indiana's robust life sciences ecosystem, serving as a critical bridge between academia, industry, and government.

While its scope is broad, BioCrossroads manages dedicated investment vehicles, most notably the Indiana Seed Fund II. This fund specifically targets early-stage life sciences and high-tech companies located exclusively within Indiana. The investment strategy emphasizes providing crucial seed capital to promising startups, often co-investing with other venture capital firms and angel investors to complete larger funding rounds. The firm seeks to support companies with high growth potential that can contribute significantly to the state's economy and scientific advancement.

Through the Indiana Seed Fund II, which was established with $15 million, BioCrossroads typically provides initial investments ranging from $250,000 to $500,000. This capital is designed to help early-stage companies achieve critical milestones, such as product development, clinical trials, or market entry. Since its inception, the Indiana Seed Fund II has played a vital role in funding over 20 companies, contributing significantly to the growth and sustainability of Indiana's burgeoning life sciences industry. BioCrossroads' broader impact extends to fostering a robust entrepreneurial environment, attracting talent, and facilitating partnerships across various sectors.